Quarterly report pursuant to Section 13 or 15(d)

SHARE BASED PAYMENTS (Tables)

v3.21.2
SHARE BASED PAYMENTS (Tables)
 9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of share-based payment expense
The following table presents share-based payment expense for the nine months ended September 30, 2021 and 2020.
 
  Nine months ended September 30,
  2021 2020
Restricted stock $ 3,511  $ 3,966 
Stock options 721  2,358 
Warrants 1,115  — 
Total $ 5,347  $ 6,324 
Schedule of company’s outstanding stock purchase warrants
Restricted stock activity for the nine months ended September 30, 2021 is presented in the following table:
 
  Shares Weighted Average Grant Date Fair Value
Nonvested, December 31, 2020
 630  $ 4.15 
Granted 250  $ 40.56 
Vested (355) $ 4.48 
Forfeited (9) $ 18.54 
Nonvested, September 30, 2021
 516  $ 19.92 
Schedule of company’s outstanding stock purchase warrants
The table below summarizes all option activity under all plans during the nine months ended September 30, 2021:
 
Options Shares Weight -
Average
Exercise
Price		 Weighted -
Average
Remaining
Contractual
Term		 Weighted -
Average
Grant Date
Fair Value
Outstanding at December 31, 2020
 1,803  $ 3.92  3.47 $ 2.38 
Granted —  —  —  — 
Exercised (821) 3.20  —  1.71 
Forfeited or expired (51) 4.12  —  2.26 
Outstanding at September 30, 2021
 931  $ 4.55  3.12 $ 2.62 
Options vested at September 30, 2021
 595  $ 4.27  3.01 $ 2.51 
Schedule of company’s outstanding stock purchase warrants
A summary of the status of the Company’s outstanding stock purchase warrants for the nine months ended September 30, 2021 is as follows:
 
  Warrants Weighted Average
Exercise Price
Outstanding at December 31, 2020
 1,393  $ 7.49 
Issued —  — 
Exercised (968) $ 2.84 
Forfeited —  — 
Outstanding at September 30, 2021
 425  $ 17.25